Evidence map›Paper›PMID 23840424›Full record

ArticlePloS one2013

Osmotic stress changes the expression and subcellular localization of the Batten disease protein CLN3.

Amanda Getty, Attila D Kovács, Tímea Lengyel-Nelson, Andrew Cardillo, Caitlin Hof, Chun-Hung Chan, David A Pearce

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Autophagy in the Neuronal Ceroid Lipofuscinoses (Batten Disease).Frontiers in cell and developmental biology · 2022
    Review
  3. Altered protein secretion in Batten disease.Disease models & mechanisms · 2021
    Review
  4. Article
  5. Frontiers in cellular neuroscience · 2021
    Review
  6. Review
  7. Article
  8. Review
  9. Discovery ofAntioxidants (Basel, Switzerland) · 2020
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Lysosome dysfunction in the pathogenesis of kidney diseases.Pediatric nephrology (Berlin, Germany) · 2014
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Amanda GettySanford Children's Health Research Center, Sanford Research/USD, Sioux Falls, South Dakota, USA.
Attila D Kovács
Tímea Lengyel-Nelson
Andrew Cardillo
Caitlin Hof
Chun-Hung Chan
David A Pearce
Sanford Research · US

Funding

The Autoimmune Response of Battens DiseaseR01NS044310 · NINDS · UNIVERSITY OF ROCHESTER · PI PEARCE, DAVID A. · 2003 to 2011
$2.3M
AMPA receptor attenuation as a new therapeutic approach for Batten diseaseR21NS067147 · NINDS · SANFORD RESEARCH/USD · PI PEARCE, DAVID A. · 2009 to 2010
$452k
NINDS NIH HHS R01 NS044310NINDS NIH HHS R21 NS067147
6 · The paper itself

Abstract

Juvenile CLN3 disease (formerly known as juvenile neuronal ceroid lipofuscinosis) is a fatal childhood neurodegenerative disorder caused by mutations in the CLN3 gene. CLN3 encodes a putative lysosomal transmembrane protein with unknown function. Previous cell culture studies using CLN3-overexpressing vectors and/or anti-CLN3 antibodies with questionable specificity have also localized CLN3 in cellular structures other than lysosomes. Osmoregulation of the mouse Cln3 mRNA level in kidney cells was recently reported. To clarify the subcellular localization of the CLN3 protein and to investigate if human CLN3 expression and localization is affected by osmotic changes we generated a stably transfected BHK (baby hamster kidney) cell line that expresses a moderate level of myc-tagged human CLN3 under the control of the human ubiquitin C promoter. Hyperosmolarity (800 mOsm), achieved by either NaCl/urea or sucrose, dramatically increased the mRNA and protein levels of CLN3 as determined by quantitative real-time PCR and Western blotting. Under isotonic conditions (300 mOsm), human CLN3 was found in a punctate vesicular pattern surrounding the nucleus with prominent Golgi and lysosomal localizations. CLN3-positive early endosomes, late endosomes and cholesterol/sphingolipid-enriched plasma membrane microdomain caveolae were also observed. Increasing the osmolarity of the culture medium to 800 mOsm extended CLN3 distribution away from the perinuclear region and enhanced the lysosomal localization of CLN3. Our results reveal that CLN3 has multiple subcellular localizations within the cell, which, together with its expression, prominently change following osmotic stress. These data suggest that CLN3 is involved in the response and adaptation to cellular stress.

Indexed as

Stress, PhysiologicalTranscriptional ActivationAdaptation, PhysiologicalAnimalsCell LineCloning, MolecularCricetinaeEndosomesGene ExpressionGlycosylationGolgi ApparatusHumansMembrane GlycoproteinsMolecular ChaperonesOsmotic PressurePromoter Regions, GeneticCLN3 protein, humanMembrane GlycoproteinsMolecular ChaperonesRNA, MessengerUbiquitin C

Identifiers

PMID23840424
PMCPMC3688782
OpenAlexW2133788641

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.